145 related articles for article (PubMed ID: 32061159)
1. Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study.
Veltroni A; Cosaro E; Spada F; Fazio N; Faggiano A; Colao A; Pusceddu S; Zatelli MC; Campana D; Piovesan A; Pia A; Grossrubatscher EM; Filice A; Bianchi A; Razzore P; Toaiari M; Cingarlini S; Landoni L; Micciolo R; Davì MV
Eur J Endocrinol; 2020 Apr; 182(4):439-446. PubMed ID: 32061159
[TBL] [Abstract][Full Text] [Related]
2. Non-functioning neuroendocrine pancreatic tumors transforming to malignant insulinomas - four cases and review of the literature.
Juhlin CC; Skoglund S; Juntti-Berggren L; Karlberg M; Calissendorff J
Neuro Endocrinol Lett; 2019 Nov; 40(4):175-183. PubMed ID: 32087093
[TBL] [Abstract][Full Text] [Related]
3. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
4. Malignant insulinoma: Report of 6 patients and literature review.
Shao Y; Qu YQ; Wang XL; Song ZG; Guo QH; Dou JT; Ba JM; Lü ZH; Mu YM
Neuro Endocrinol Lett; 2016 Jul; 37(3):189-192. PubMed ID: 27618603
[TBL] [Abstract][Full Text] [Related]
5. Synchronous Insulinoma and Glucagonoma: A Review of the Literature.
Damaskos C; Dimitroulis D; Garmpi A; Antoniou EA; Kouraklis G; Psilopatis I; Mavri M; Diamantis E; Marinos G; Kyriakos G; Farmaki P; Patsouras A; Kontzoglou K; Garmpis N
In Vivo; 2023; 37(6):2402-2408. PubMed ID: 37905620
[TBL] [Abstract][Full Text] [Related]
6. Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.
Hauck L; Bitzer M; Malek N; Plentz RR
Scand J Gastroenterol; 2016 Jan; 51(1):55-9. PubMed ID: 26137871
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumours.
Ruiz-Tovar J; Priego P; Martínez-Molina E; Morales V; Sanjuanbenito A; Lobo E
Clin Transl Oncol; 2008 Aug; 10(8):493-7. PubMed ID: 18667380
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes.
Roland CL; Bian A; Mansour JC; Yopp AC; Balch GC; Sharma R; Xie XJ; Schwarz RE
J Surg Oncol; 2012 May; 105(6):595-600. PubMed ID: 22006521
[TBL] [Abstract][Full Text] [Related]
9. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Kipnis ST; Hung M; Kumar S; Heckert JM; Lee H; Bennett B; Soulen MC; Pryma DA; Mankoff DA; Metz DC; Eads JR; Katona BW
JAMA Netw Open; 2021 Mar; 4(3):e212274. PubMed ID: 33755166
[TBL] [Abstract][Full Text] [Related]
10. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
11. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
[TBL] [Abstract][Full Text] [Related]
12. Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients.
Bégu-Le Corroller A; Valéro R; Moutardier V; Henry JF; Le Treut YP; Gueydan M; De Micco C; Sierra M; Conte-Devolx B; Oliver C; Raccah D; Favre R; Digue L; Heim M; Seitz JF; Delpero JR; Vialettes B
Diabetes Metab; 2008 Sep; 34(4 Pt 1):343-8. PubMed ID: 18556231
[TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors].
Han JH; Kim MH; Moon SH; Park SJ; Park DH; Lee SS; Seo DW; Lee SK; Kim SC; Han DJ
Korean J Gastroenterol; 2009 Feb; 53(2):98-105. PubMed ID: 19237835
[TBL] [Abstract][Full Text] [Related]
15. [Hormone inactive neuroendocrine tumors of the pancreas].
Schwab M; Knoll MR; Jentschura D; Hagmüller E
Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
[TBL] [Abstract][Full Text] [Related]
16. Insulinomas: from diagnosis to treatment. A review of the literature.
Giannis D; Moris D; Karachaliou GS; Tsilimigras DI; Karaolanis G; Papalampros A; Felekouras E
J BUON; 2020; 25(3):1302-1314. PubMed ID: 32862570
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
18. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
[TBL] [Abstract][Full Text] [Related]
20. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center.
Pape UF; Böhmig M; Berndt U; Tiling N; Wiedenmann B; Plöckinger U
Ann N Y Acad Sci; 2004 Apr; 1014():222-33. PubMed ID: 15153439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
